Gene expression changes in blood as a putative biomarker for Huntington's disease

Movement Disorders

Volumn 24, Issue 15, 2009, Pages 2277-2281

  Lovrecic, Luca ^a   Kastrin, Andrej ^a   Kobal, Jan ^a   Pirtosek, Zvezdan ^a   Krainc, Dimitri ^b   Peterlin, Borut ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Biomarkers; Gene expression; Huntington's disease; Neurodegeneration; Transcriptomics

Indexed keywords

BIOLOGICAL MARKER; CAPPING PROTEIN MUSCLE Z LINE ALPHA 1; G PROTEIN COUPLED RECEPTOR 5; HYPOXIA INDUCIBLE FACTOR 1; LIPOCORTIN 1; MEMBRANE ASSOCIATED RING FINGER 7; PROTEOLYTIC SIGNAL CONTAINING NUCLEAR PROTEIN; PURINERGIC P2Y RECEPTOR; RHO ASSOCIATED COILED COIL CONTAINING PROTEIN KINASE 1; SPLICING FACTOR 3B SUBUNIT 1; TAF7 RNA POLYMERASE II; TATA BINDING PROTEIN ASSOCIATED FACTOR; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG; YIPPEE LIKE 5 PROTEIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUNTINGTON CHOREA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSCRIPTOMICS; UPREGULATION; VALIDATION STUDY;

ADULT; ARTIFICIAL INTELLIGENCE; COHORT STUDIES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARKINSON DISEASE; RNA, MESSENGER; STROKE; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 72849144063     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22477     Document Type: Article

References (12)

1. Tang Y, Xu H, Du X, et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab 2006;26:1089-1102.
2. Tang Y, Schapiro MB, Franz DN, et al. Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1 and Down's syndrome. Ann Neurol 2004;56:808-814.
3. Bomprezzi R, Ringner M, Kim S, et al. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet 2003;12:2191-2199. (Pubitemid 37098989)
4. Tang Y, Gilbert DL, Glauser TA, Hershey AD, Sharp FR. Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch Neurol 2005;62:210-215. (Pubitemid 40204742)
5. Scherzer CR, Eklund AC, Morse LJ, et al. Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci USA 2007;104:995-1960
6. Borovecki F, Lovrecic L, Zhou J, et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci USA 2005;102:11023-11028. (Pubitemid 41105986)
7. Harper PS. Huntington's disease. Major problems in neurology. London: W.B. Saunders Company Ltd; 1996.
8. Huntington Study Group. Unified Huntington's disease rating scale: reliability and consistency. Mov Disord 1996;11:136-142. (Pubitemid 26082779)
9. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
10. Frank E, Witten, IH. Data mining: practical machine learning tools and techniques, 2nd ed. San Francisco:MorganKaufmann; 2005.
11. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computation; 2007.
12. Runne H, Kuhn A, Wild EJ, et al. Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood. Proc Natl Acad Sci USA 2007;104:14424-14429. (Pubitemid 350003277)